Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2888 | 2122 | 36.7 | 75% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
530 | 3 | SPLENECTOMY//COMMON VARIABLE IMMUNODEFICIENCY//IMMUNE THROMBOCYTOPENIA | 19898 |
1704 | 2 | COMMON VARIABLE IMMUNODEFICIENCY//PRIMARY IMMUNODEFICIENCY//INTRAVENOUS IMMUNOGLOBULIN | 6726 |
2888 | 1 | INTRAVENOUS IMMUNOGLOBULIN//IVIG//SUBCUTANEOUS IMMUNOGLOBULIN | 2122 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INTRAVENOUS IMMUNOGLOBULIN | authKW | 1849290 | 21% | 28% | 452 |
2 | IVIG | authKW | 874255 | 9% | 31% | 198 |
3 | SUBCUTANEOUS IMMUNOGLOBULIN | authKW | 526171 | 2% | 76% | 48 |
4 | IGIV | authKW | 230202 | 1% | 80% | 20 |
5 | HIZENTRA | authKW | 143881 | 0% | 100% | 10 |
6 | SCIG | authKW | 143371 | 1% | 59% | 17 |
7 | PRIMARY IMMUNODEFICIENCY DISEASE | authKW | 112824 | 1% | 39% | 20 |
8 | INTRAVENOUS IMMUNOGLOBULIN IVIG | authKW | 102824 | 1% | 31% | 23 |
9 | SUBCUTANEOUS IMMUNOGLOBULIN THERAPY | authKW | 100717 | 0% | 100% | 7 |
10 | PRIMARY IMMUNODEFICIENCY | authKW | 100319 | 3% | 10% | 69 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 12042 | 37% | 0% | 776 |
2 | Hematology | 5886 | 17% | 0% | 352 |
3 | Allergy | 3230 | 6% | 0% | 126 |
4 | Medicine, General & Internal | 1085 | 12% | 0% | 252 |
5 | Rheumatology | 1032 | 4% | 0% | 91 |
6 | Clinical Neurology | 565 | 9% | 0% | 182 |
7 | Pharmacology & Pharmacy | 388 | 10% | 0% | 221 |
8 | Pediatrics | 158 | 4% | 0% | 85 |
9 | Critical Care Medicine | 122 | 2% | 0% | 39 |
10 | Infectious Diseases | 60 | 2% | 0% | 51 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EQUIPE IMMUNOPATHOL THER EUT IMMUNOINTERVENT 1 | 86829 | 1% | 46% | 13 |
2 | HOSP ST GEORG GMBH LEIPZIG | 59949 | 0% | 83% | 5 |
3 | INT ASSOCIATED IMPACT | 52964 | 0% | 41% | 9 |
4 | CHAIR AUTOIMMUNE DIS | 44959 | 0% | 63% | 5 |
5 | EQUIPE RECH CORDELIERS 16 | 43164 | 0% | 100% | 3 |
6 | BIOCHEM MICROBIOL BIOINFORMAT | 29348 | 0% | 20% | 10 |
7 | BIOCHEM QUAL CONTROL | 28776 | 0% | 100% | 2 |
8 | HOSP AGATHARIED | 28776 | 0% | 100% | 2 |
9 | INT ASSOCIATED IMPACT SANTE RECH | 28776 | 0% | 100% | 2 |
10 | JEFFREY MODELL PRIMARY IMMUNE DEFICIENCIES | 28776 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CLINICAL IMMUNOLOGY | 74220 | 5% | 5% | 114 |
2 | VOX SANGUINIS | 38126 | 5% | 3% | 102 |
3 | CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 16544 | 5% | 1% | 114 |
4 | BIOLOGICALS | 9470 | 1% | 2% | 30 |
5 | TRANSFUSION | 6024 | 3% | 1% | 57 |
6 | INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN | 5924 | 1% | 2% | 17 |
7 | IMMUNOTHERAPY | 3889 | 1% | 2% | 14 |
8 | CLINICAL IMMUNOLOGY | 2810 | 1% | 1% | 23 |
9 | AUTOIMMUNITY REVIEWS | 2738 | 1% | 1% | 18 |
10 | CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 2423 | 1% | 1% | 24 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTRAVENOUS IMMUNOGLOBULIN | 1849290 | 21% | 28% | 452 | Search INTRAVENOUS+IMMUNOGLOBULIN | Search INTRAVENOUS+IMMUNOGLOBULIN |
2 | IVIG | 874255 | 9% | 31% | 198 | Search IVIG | Search IVIG |
3 | SUBCUTANEOUS IMMUNOGLOBULIN | 526171 | 2% | 76% | 48 | Search SUBCUTANEOUS+IMMUNOGLOBULIN | Search SUBCUTANEOUS+IMMUNOGLOBULIN |
4 | IGIV | 230202 | 1% | 80% | 20 | Search IGIV | Search IGIV |
5 | HIZENTRA | 143881 | 0% | 100% | 10 | Search HIZENTRA | Search HIZENTRA |
6 | SCIG | 143371 | 1% | 59% | 17 | Search SCIG | Search SCIG |
7 | PRIMARY IMMUNODEFICIENCY DISEASE | 112824 | 1% | 39% | 20 | Search PRIMARY+IMMUNODEFICIENCY+DISEASE | Search PRIMARY+IMMUNODEFICIENCY+DISEASE |
8 | INTRAVENOUS IMMUNOGLOBULIN IVIG | 102824 | 1% | 31% | 23 | Search INTRAVENOUS+IMMUNOGLOBULIN+IVIG | Search INTRAVENOUS+IMMUNOGLOBULIN+IVIG |
9 | SUBCUTANEOUS IMMUNOGLOBULIN THERAPY | 100717 | 0% | 100% | 7 | Search SUBCUTANEOUS+IMMUNOGLOBULIN+THERAPY | Search SUBCUTANEOUS+IMMUNOGLOBULIN+THERAPY |
10 | PRIMARY IMMUNODEFICIENCY | 100319 | 3% | 10% | 69 | Search PRIMARY+IMMUNODEFICIENCY | Search PRIMARY+IMMUNODEFICIENCY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHERIN, P , MARIE, I , MICHALLET, M , PELUS, E , DANTAL, J , CRAVE, JC , DELAIN, JC , VIALLARD, JF , (2016) MANAGEMENT OF ADVERSE EVENTS IN THE TREATMENT OF PATIENTS WITH IMMUNOGLOBULIN THERAPY: A REVIEW OF EVIDENCE.AUTOIMMUNITY REVIEWS. VOL. 15. ISSUE 1. P. 71 -81 | 115 | 86% | 3 |
2 | SPATH, PJ , GRANATA, G , LA MARRA, F , KUIJPERS, TW , QUINTI, I , (2015) ON THE DARK SIDE OF THERAPIES WITH IMMUNOGLOBULIN CONCENTRATES: THE ADVERSE EVENTS.FRONTIERS IN IMMUNOLOGY. VOL. 6. ISSUE . P. - | 95 | 75% | 6 |
3 | JOLLES, S , ORANGE, JS , GARDULF, A , STEIN, MR , SHAPIRO, R , BORTE, M , BERGER, M , (2015) CURRENT TREATMENT OPTIONS WITH IMMUNOGLOBULIN G FOR THE INDIVIDUALIZATION OF CARE IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE.CLINICAL AND EXPERIMENTAL IMMUNOLOGY. VOL. 179. ISSUE 2. P. 146 -160 | 62 | 87% | 13 |
4 | SRIAROON, P , BALLOW, M , (2015) IMMUNOGLOBULIN REPLACEMENT THERAPY FOR PRIMARY IMMUNODEFICIENCY.IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. VOL. 35. ISSUE 4. P. 713 -+ | 61 | 95% | 2 |
5 | STIEHM, ER , (2013) ADVERSE EFFECTS OF HUMAN IMMUNOGLOBULIN THERAPY.TRANSFUSION MEDICINE REVIEWS. VOL. 27. ISSUE 3. P. 171-178 | 63 | 79% | 39 |
6 | SAEEDIAN, M , RANDHAWA, I , (2014) IMMUNOGLOBULIN REPLACEMENT THERAPY: A TWENTY-YEAR REVIEW AND CURRENT UPDATE.INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. VOL. 164. ISSUE 2. P. 151 -166 | 61 | 92% | 6 |
7 | ABOLHASSANI, H , SADAGHIANI, MS , AGHAMOHAMMADI, A , OCHS, HD , REZAEI, N , (2012) HOME-BASED SUBCUTANEOUS IMMUNOGLOBULIN VERSUS HOSPITAL-BASED INTRAVENOUS IMMUNOGLOBULIN IN TREATMENT OF PRIMARY ANTIBODY DEFICIENCIES: SYSTEMATIC REVIEW AND META ANALYSIS.JOURNAL OF CLINICAL IMMUNOLOGY. VOL. 32. ISSUE 6. P. 1180 -1192 | 54 | 93% | 32 |
8 | TICHY, EM , VAUGHAN, L , (2016) SELECTING A POLYCLONAL IMMUNE GLOBULIN TREATMENT FOR A PATIENT WITH PRIMARY IMMUNE DEFICIENCY DISEASE: ROLE OF THE CLINICAL PHARMACIST.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 73. ISSUE 8. P. 533 -546 | 58 | 91% | 0 |
9 | LINGMAN-FRAMME, J , FASTH, A , (2013) SUBCUTANEOUS IMMUNOGLOBULIN FOR PRIMARY AND SECONDARY IMMUNODEFICIENCIES: AN EVIDENCE-BASED REVIEW.DRUGS. VOL. 73. ISSUE 12. P. 1307 -1319 | 53 | 91% | 18 |
10 | SANCHEZ-RAMON, S , CORBI, AL , FIDALGO, AG , DOMINGUEZ-SOTO, A , (2016) SUBCUTANEOUS IMMUNOGLOBULINS: A PROMISING ALTERNATIVE FOR IMMUNOMODULATION?.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 41. P. 6300 -6305 | 56 | 79% | 1 |
Classes with closest relation at Level 1 |